CNBC's Meg Tirrell reports prosecutors may file new charges against Martin Shkreli. His next court hearing is set for June 6th. » Read More
Marvina is a premium cannabis provider that offers a monthly delivery service of marijuana to consumers in San Francisco.
Regeneron Pharmaceuticals CEO Dr. Leonard Schleifer told CNBC on Tuesday that benefits companies should not try to practice medicine.
The Justice Department kept a secret database of incoming and outgoing U.S. international calls for more than a decade.
"Any event in life changes one. That was an event that probably changed me in many ways. I think I am a better person," biotech company founder Sam Waksal.
This flu season is ramping up earlier than last year's, NBC News reports.
Hallucinogenic mushrooms have been discovered on the grounds of Buckingham Palace in London, NBC News reports.
Drug giant Merck said it will buy Cubist and its slate of medicines administered in hospitals, many for bacterial infections, for about $9.5 billion.
There is no escaping the fact that we’re all getting older, and investors are having to find new ways to make money from changes in the way we age.
Bob Marley heirs say they are creating a pot-focused brand dubbed Marley Natural, reports NBC News.
Law enforcement agencies around the globe undertook action against so-called "dark markets" running anonymously on the "Tor" network, on Thursday.
Along the Myanmar-China border, where heroin addiction is common, fresh needles are now so coveted that shopkeepers dispense them as change.
A nasty Wall Street divorce has touched two biotech CEOs and appears to have moved their company stocks down over drug use allegations.
Health care has been on a tear in 2014, and there is still room for upside. Wall Street analysts are focusing on the following four trends.
With some 84 million people in the U.S. struggling with obesity, investing in obesity stocks has become a Wall Street trend.
Although the US spent $7.6 billion to eradicate poppy in Afghanistan, cultivation of the opium source is at an all time high.
GlaxoSmithKline (GSK) reported third-quarter revenue lower than analysts forecast, as sales of blockbuster asthma drug Advair continued to fall.
The market share of U.K. supermarket Tesco continues to shrink, but data shows the retailer may have turned a corner as the slide eases.
GlaxoSmithKline, which was slapped with a record fine for corruption in China, said it was looking into allegations of corruption in UAE.
Chimerix said its experimental Ebola drug has been provided for potential use in patients, sending its shares sharply higher in premarket trading.
A new breast cancer drug from Roche has shown "unprecedented" benefits in extending lives in a clinical trial.